67 related articles for article (PubMed ID: 9989801)
41. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.
Toussaint-Smith E; Donner DB; Roman A
Oncogene; 2004 Apr; 23(17):2988-95. PubMed ID: 14968115
[TBL] [Abstract][Full Text] [Related]
42. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential.
Liu Z; Ghai J; Ostrow RS; Faras AJ
Virology; 1995 Feb; 207(1):260-70. PubMed ID: 7871737
[TBL] [Abstract][Full Text] [Related]
43. Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes.
Steinmann KE; Pei XF; Stöppler H; Schlegel R; Schlegel R
Oncogene; 1994 Feb; 9(2):387-94. PubMed ID: 8290252
[TBL] [Abstract][Full Text] [Related]
44. High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins.
Havard L; Rahmouni S; Boniver J; Delvenne P
Virology; 2005 Jan; 331(2):357-66. PubMed ID: 15629778
[TBL] [Abstract][Full Text] [Related]
45. Stable transgene expression in tumors and metastases after transduction with lentiviral vectors based on human immunodeficiency virus type 1.
Bao L; Jaligam V; Zhang XY; Kutner RH; Kantrow SP; Reiser J
Hum Gene Ther; 2004 May; 15(5):445-56. PubMed ID: 15144575
[TBL] [Abstract][Full Text] [Related]
46. Induction of chromosome abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene.
Hashida T; Yasumoto S
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1569-77. PubMed ID: 1649895
[TBL] [Abstract][Full Text] [Related]
47. Lack of immortalizing activity of a human papillomavirus type 16 variant DNA with a mutation in the E2 gene isolated from normal human cervical keratinocytes.
Storey A; Greenfield I; Banks L; Pim D; Crook T; Crawford L; Stanley M
Oncogene; 1992 Mar; 7(3):459-65. PubMed ID: 1312701
[TBL] [Abstract][Full Text] [Related]
48. Loss of expression of a retrovirus-transduced gene in human keratinocytes.
Fenjves ES; Yao SN; Kurachi K; Taichman LB
J Invest Dermatol; 1996 Mar; 106(3):576-8. PubMed ID: 8648197
[TBL] [Abstract][Full Text] [Related]
49. Different immortalized keratinocyte cell lines display distinct capabilities to differentiate and reconstitute an epidermis in vitro.
Jahn M; Lang V; Diehl S; Back R; Kaufmann R; Fauth T; Buerger C
Exp Dermatol; 2024 Jan; 33(1):e14985. PubMed ID: 38043130
[TBL] [Abstract][Full Text] [Related]
50. The majority of keratinocytes incorporate intradermally injected plasmid DNA regardless of size but only a small proportion of cells can express the gene product.
Sawamura D; Yasukawa K; Kodama K; Yokota K; Sato-Matsumura KC; Toshihiro T; Shimizu H
J Invest Dermatol; 2002 Jun; 118(6):967-71. PubMed ID: 12060390
[TBL] [Abstract][Full Text] [Related]
51. High-level secretion of growth hormone by retrovirally transduced primary human keratinocytes: prospects for an animal model of cutaneous gene therapy.
Peroni CN; Cecchi CR; Damiani R; Soares CR; Ribela MT; do Rocio Arkaten R; Bartolini P
Mol Biotechnol; 2006 Oct; 34(2):239-45. PubMed ID: 17172669
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
[TBL] [Abstract][Full Text] [Related]
53. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
54. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.
Aguilar-Lemarroy A; Gariglio P; Whitaker NJ; Eichhorst ST; zur Hausen H; Krammer PH; Rösl F
Oncogene; 2002 Jan; 21(2):165-75. PubMed ID: 11803460
[TBL] [Abstract][Full Text] [Related]
55. Biologic aspects of expression of stably integrated transgenes in cells of the skin in vitro and in vivo.
Krueger GG; Morgan JR; Petersen MJ
Proc Assoc Am Physicians; 1999; 111(3):198-205. PubMed ID: 10354359
[TBL] [Abstract][Full Text] [Related]
56. Persistent transgene expression and normal differentiation of immortalized human keratinocytes in vivo.
Krueger GG; Jorgensen CM; Matsunami N; Morgan JR; Liimatta A; Meloni-Ehrig A; Shepard R; Petersen MJ
J Invest Dermatol; 1999 Feb; 112(2):233-9. PubMed ID: 9989801
[TBL] [Abstract][Full Text] [Related]
57. Use of cloned genetically modified human fibroblasts to assess long-term survival in vivo.
Krueger GG; Jorgensen CM; Petersen MJ; Mansbridge JN; Morgan JR
Hum Gene Ther; 1997 Mar; 8(5):523-32. PubMed ID: 9095404
[TBL] [Abstract][Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
